A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

Clinical trial NCT01100307 · COMPLETED

Trial details

NCT number: NCT01100307
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Edema Diabetic Mellitus Retinal Disease

Start date: 2010-05-01
Primary completion: 2012-08-01
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.